FDA Investigator Doreen P Gubbay

Doreen P Gubbay has inspections in 2 countries as of 03 Aug 2023. Doreen P Gubbay has collaborated with a combinined 2297 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
95
Last Inspection Date:
03 Aug 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, France
Co-Investigator(s):
Addam S Reynolds, Allen Lou, Amy Codella, Amy L Singer, Amy M Codella, Amy M Cramer, Annemarie B Randow, Annemarie Bodnar, Annet R Rajan, Anthony M Criscuolo, Jr, Antoinette L Ravelli, Atul J Agrawal, Barbara J Maulfair, Brandon M Kurjanowicz, Byungja E Marciante, Cary Greene, Charles J Chacko, Charlotte P Chang, Colin E Tack, Daniel J Grabicki, Daval H Patel, David H Smith, Dawn L Wydner, Deborah B Nixon, Denise M Visco, Investigator, Dessa A Antoine, Devon Jenkins, Dhaval H Patel, Diane B Radice, Doreen P Canetti, Dorothy J Denes, Edward D Mcdonald, Edward Oshaughnessy, Emest F Bizjak, Emmanuel J Ramos, Eric J Cunningham, Eric Rothschild, Esteban Beltran, Frank J Marciniak, Frederick Razzaghi, George Pyramides, Gianine E Delade, Gianine E Tompkins, Gillian B Nardelli, Gobiga Vanniyasingam, Harry J Brewer, Herrmann, Hitesh R Patel, Jacqueline A O'shaughnessy, PhD, Jacqueline S Warner, James R Birkenstamm, Janet Pulver, Jason Kwong, Jean Blackston Hill, Jean M Kelahan, Jennifer A Bazergui, Jennifer L Custodio, Jennifer Macmillan, Jessica M Monteiro, Jo Annc Declement, Jonathan Ho, Jonee J Mearns, Jose M Cayuela, Joseph F Mcginnis, RPh, Joy Rkozlowski Klena, Justin A Boyd, Justine Tomasso, Karen A Spencer, Karen F Tomaziefski, Kelli F Dobilas, Kelly Doremus, Kelly I Anderson, King, Kinh Q Mac, Kristen E Rescigno, Kristy A Zielny, Kwong P Lee, Kyle D Covill, Lata C Mathew, PhD, Lauren L Vajo, Li Li, Lisa Harlan, Loretta Nemchik, Marcelo O Mangalindan, Jr, Marcia Gelber, Margaret M Sands, Maria Estrella, Matthew D Schnittker, Matthew W Kyle, Melissa A Freeman, Melissa B Libby, Meredith L Sheridan, Meyer, Michael R Klapal, Michael Rosner, Michael Serrano, Mielziner, Monica L Gutierrez, Nancy M Espinal, Nerizza B Guerin, Nicholas A Violand, Nicholas C Mendiola, Paul L Bellamy, Peter R Lenahan, Ramanda C Gregory, Raymond L Cheung, Regina T Brown, Remache, Richard D Manney, Robert D Tollefsen, Robert G Ruff, Robert W Calais, Robin P Mathew, Russell J Glapion, Sands, Sarah Adella Fave, Sarah Forney, Schultz, Sean G Casey, Sherri J Liu, Shirley S Wen, State Agency, Stephanie T Durso, Stephen J Mottola, Steven M Weinman, Tania E Vizcaino, Tara K Carmody, Thai T Duong, Tressa T Lewis, Valerie C Reed, Wayne J Meyer, William J Muszynski, William R Chang, Willy A Orantes

Doreen P Gubbay's Documents

Publish Date Document Type Title
December, 2014 FDA 483 Compression Therapy Concepts, Inc. - Form 483, 2014-12-05
June, 2010 EIR Aspire Pharmaceuticals Inc. - EIR, 2010-06-21
August, 2013 FDA 483 Prosec Protection Systems, Inc. - Form 483, 2013-08-02
June, 2010 FDA 483 Response Aspire Pharmaceuticals Inc. - Form 483R, 2010-07-01
October, 2014 FDA 483 NutraStar, Inc. - Form 483, 2014-10-06
August, 2010 EIR Reliance Private Label Supplements - EIR, 2010-08-03
May, 2014 FDA 483 Flawless Beauty LLC - Form 483, 2014-05-16
August, 2011 FDA 483 Access Bio, Inc. - Form 483, 2011-09-12
July, 2015 FDA 483 Valeant Pharmacueticals North America LLC - Form 483, 2015-08-31
June, 2012 FDA 483 Maquet Cardiovascular, LLC - Form 483, 2012-06-14
January, 2016 EIR NutraBio Labs, Inc. - EIR, 2016-01-29
June, 2012 FDA 483 Response Maquet Cardiovascular, LLC - Form 483R, 2012-07-03
December, 2011 FDA 483 Prosec Protection Systems, Inc. - Form 483, 2011-12-22
June, 2014 FDA 483 The LifeStyle Company, Inc. - Form 483, 2014-06-27
August, 2014 FDA 483 Rasi Laboratories, Inc. - Form 483, 2014-08-05
March, 2014 FDA 483 NutraStar, Inc. - Form 483, 2014-03-11
January, 2014 FDA 483 Temptime Corporation - Form 483, 2014-01-02
November, 2013 FDA 483 Nephros, Inc. - Form 483, 2013-11-13
October, 2014 FDA 483 Vynacron Dental Resins, Inc. - Form 483, 2014-10-29
March, 2013 FDA 483 Agfa Healthcare Corporation - Form 483, 2013-03-29
June, 2010 FDA 483 Aspire Pharmaceuticals Inc. - Form 483, 2010-06-21

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more